AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 94 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $12,114 | -64.8% | 41,774 | -45.4% | 0.00% | -50.0% |
Q4 2022 | $34,413 | -14.0% | 76,490 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $40,000 | +2.6% | 76,490 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $39,000 | -77.8% | 76,490 | 0.0% | 0.00% | -83.3% |
Q1 2022 | $176,000 | -51.5% | 76,490 | 0.0% | 0.01% | -47.8% |
Q4 2021 | $363,000 | -40.3% | 76,490 | 0.0% | 0.02% | -45.2% |
Q3 2021 | $608,000 | -50.0% | 76,490 | -56.2% | 0.04% | -52.3% |
Q2 2021 | $1,216,000 | -12.1% | 174,646 | 0.0% | 0.09% | -23.5% |
Q1 2021 | $1,383,000 | +0.7% | 174,646 | 0.0% | 0.12% | -12.9% |
Q4 2020 | $1,374,000 | +11.0% | 174,646 | 0.0% | 0.13% | -5.0% |
Q3 2020 | $1,238,000 | -23.3% | 174,646 | 0.0% | 0.14% | -33.2% |
Q2 2020 | $1,615,000 | +54.3% | 174,646 | -22.3% | 0.21% | +23.8% |
Q1 2020 | $1,047,000 | -44.0% | 224,646 | -8.2% | 0.17% | -38.5% |
Q4 2019 | $1,869,000 | -8.2% | 244,646 | -7.6% | 0.27% | -17.3% |
Q3 2019 | $2,035,000 | +2.3% | 264,646 | -8.9% | 0.33% | -2.9% |
Q2 2019 | $1,990,000 | -14.9% | 290,534 | 0.0% | 0.34% | -20.6% |
Q1 2019 | $2,339,000 | +7.5% | 290,534 | 0.0% | 0.43% | -13.2% |
Q4 2018 | $2,176,000 | – | 290,534 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $532,000 | 6.17% |
Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |